{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"PIWORLD Investor Podcasts","title":"Benchmark (BMK) full year 2021 results presentation - November 2021","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/08a78b3f\"></iframe>","width":"100%","height":180,"duration":1954,"description":"Benchmark's CEO, Trond Williksen and CFO, Septima Maguire present the full year results for the period ended 30th September 2021.\nTrond Williksen, CEO00:17 – Introduction00:52 – Highlights of the period04:21 – Performance highlights06:48 – Operational highlights\nSeptima Maguire, CFO13:16 – Financial review15:44 – Segmental highlights23:07 – Cash flow24:29 – Looking forward\nTrond Williksen, CEO26:22 – Strategy28:23 – ‘One Benchmark’ opportunities29:33 – Current trading & Outlook31:07 – Investment case31:36 – Closing remarks\nBenchmark Holdings plc is engaged in the provision of aquaculture health, genetics and nutrition. The Company’s segments include genetics, advanced nutrition and health. The Company develops products that helps fish and shrimp to improve their sustainability and profitability by improving yield, quality, and by reducing mortality. The Company’s products include high genetic quality ova for salmon, shrimp and tilapia, and breeding, program, specialist feeds for early stage shrimp and fish; probiotics, biocides and medicines.","thumbnail_url":"https://img.transistorcdn.com/oB5fNE4aIAia_YyTCKvE1PzrZQaD1Fjo_P7m7T9Aw_Y/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTJi/ODBiMzBmOGFhZWJi/MWEzYThkMzAyNmZm/MTdjZi5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}